Cerus (CERS) Revenue Growth (5y) (2015 - 2026)
Cerus (CERS) Revenue Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.85 Bn | 176.55 Bn | 6.27 Bn |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn |
| 3 | Medtronic | 108.55 Bn | 99.33 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.24 Bn | 44.57 Bn | 1.29 Bn |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.15 Bn | 25.87 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 24.75 Bn | 21.63 Bn | 2.07 Bn |
| 10 | Cerus | 604.75 Mn | 524.33 Mn | 27.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.90% |
| Dec 31, 2025 | 7.33% |
| Sep 30, 2025 | 65.08% |
| Jun 30, 2025 | -48.05% |
| Mar 31, 2025 | 167.79% |
| Dec 31, 2024 | 66.77% |
| Sep 30, 2024 | 10.58% |
| Jun 30, 2024 | 47.81% |
| Mar 31, 2024 | 53.17% |
| Dec 31, 2023 | 62.19% |
| Sep 30, 2023 | -59.16% |
| Jun 30, 2023 | 57.20% |
| Mar 31, 2023 | 0.67% |
| Dec 31, 2022 | 63.02% |
| Sep 30, 2022 | -8.91% |
| Jun 30, 2022 | 89.74% |
| Mar 31, 2022 | 16.14% |
| Dec 31, 2021 | 62.39% |
| Sep 30, 2021 | -10.11% |
| Jun 30, 2021 | 9.63% |